SCHEMBL7545873

SCHEMBL7545873

NC(=O)NC1CC2CCC(C1)N2Cc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.65
LMNA P02545 1/20 0.63
ALDH1A1 P00352 2/20 0.62
KMT2A Q03164 5/20 0.61
MEN1 O00255 4/20 0.61
OPRK1 P41145 3/20 0.61
OPRM1 P35372 1/20 0.61
OPRD1 P41143 1/20 0.61
KCNH2 Q12809 1/20 0.61
USP2 O75604 1/20 0.60
CYP2D6 P10635 1/20 0.57
CYP2C19 P33261 1/20 0.57
MAPT P10636 1/20 0.57
MAPK1 P28482 1/20 0.57
LTA4H P09960 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7537772 0.94 LMNA (0.71) L3MBTL1LMNAALDH1A1KMT2AOPRK1
SCHEMBL4274767 0.88 L3MBTL1 (0.68) L3MBTL1LMNAALDH1A1KMT2AMEN1
SCHEMBL13649145 0.87 KMT2A (0.60) L3MBTL1LMNAALDH1A1KMT2AMEN1
SCHEMBL12642622 0.87 KMT2A (0.60) L3MBTL1LMNAALDH1A1KMT2AMEN1
SCHEMBL3595934 0.86 KMT2A (0.78) L3MBTL1LMNAALDH1A1KMT2AMEN1
SCHEMBL1886766 0.86 KMT2A (0.78) L3MBTL1LMNAALDH1A1KMT2AMEN1
SCHEMBL15249477 0.86 KMT2A (0.78) L3MBTL1LMNAALDH1A1KMT2AMEN1
SCHEMBL16250460 0.86 KMT2A (0.78) L3MBTL1LMNAALDH1A1KMT2AMEN1
SCHEMBL3595931 0.86 KMT2A (0.78) L3MBTL1LMNAALDH1A1KMT2AMEN1
SCHEMBL3589020 0.84 LMNA (0.81) L3MBTL1LMNAALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1254123-A1 2-BENZOTHIAZOLYL UREA DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2002-11-06 EP disclosed
WO-2001057008-A1 2-BENZOTHIAZOLYL UREA DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-08-09 WO disclosed